1. Munder, P.G. (1981) inAugmenting Agents in Cancer Therapy (Hersh, E.M., Chirigos, M.A., and Mastrangelo, M.J., eds.) pp. 441–458, Raven Press, New York.
2. Berdel, W.E. (1986) inAntineoplastische Wirkung von Aetherlipid-Derivaten, Thieme, Stuttgart/New York.
3. Tidwell, T., Guzman, G., and Vogler, W.R. (1981)Blood 57, 794–797.
4. Andreesen, R., Modolell, M., Weltzien, H.U., Eibl, H., Common, H.H., Löhr, G.W., and Munder, P.G. (1978)Cancer Res. 38, 3894–3899.
5. Neumann, H.A., Runge, H.M., Herrmann, D.J.B., Fiebig, H.H., and Engelhardt, R. (1986)J. Cancer Res. Clin. Oncol. 111 Suppl., 23.